FOUNDATION MEDICINE, INC.

Foundation Medicine, Inc. specializes in advanced genomic testing and molecular diagnostics for precision oncology, delivering next-generation sequencing (NGS) and molecular tumor profiling services to support clinical decision-making. Their core capabilities encompass comprehensive genomic profiling of solid and hematologic malignancies, including tumor mutational burden analysis, microsatellite instability assessment, and fusion detection via NGS platforms. The contractor provides FDA-authorized, CLIA-certified laboratory services that enable personalized treatment pathways, with deep expertise in interpreting complex genomic data for therapeutic selection and clinical trial matching. Their technical differentiation lies in scalable, high-throughput genomic analytics tailored for real-world clinical environments, ensuring rapid turnaround and actionable insights for oncologists and care teams. The company maintains a consistent, long-standing relationship with the Department of Veterans Affairs, delivering genomic sequencing and molecular laboratory services across multiple VA medical centers. Work includes routine genomic testing for hematologic and solid tumors, as well as specialized services aligned with executive orders on precision medicine, demonstrating a trusted, repeat partnership focused on improving veteran cancer care through advanced diagnostics. Foundation Medicine operates primarily under NAICS 621511, which defines medical laboratories providing clinical diagnostic services. Their market positioning centers on precision oncology diagnostics within the federal healthcare system, serving as a specialized provider of molecular pathology services that bridge genomic research and clinical oncology practice. As a privately held entity headquartered in Cambridge, Massachusetts, Foundation Medicine operates as a non-certified small business with no federal small business certifications on record. The company’s physical and operational presence is anchored in Massachusetts, supporting federal healthcare missions through its accredited laboratory infrastructure and clinical bioinformatics capabilities.